glp 1 agonist or antagonist GLP-1 Agonists - What is it? Impact of GLP- 1 Receptor

In the safety profile, pooling three studies with 640 patients, most adverse events associated with retatrutide were mild and did not result in treatment discontinuation

Rehab Abdelhamid: Writing review & editing, Validation, Investigation, Formal analysis, Conceptualization

They named it 'glucagon' (GLUCose-AGONist) on account that it seemed to be a 'glucose driving hormone' (Unger

Retatrutide: A Triple Agonist with Unprecedented Efficacy Retatrutide (LY3437943) is a novel triple incretin agonist that simultaneously targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors

2010, doi: 10.1111/j.2040-1124.2010.00022.x